Search research articles
Contact Us
Filters
Showing results (1-10 of 47) with videos related to
Page
of 5
Sort By:
Lancet (London, England)
|
October 15, 2015
EXAMINE: targeting risk and treatment in diabetes
Daniel M Riche, Courtney Davis
Journal of the American College of Cardiology
|
October 24, 2007
A perspective on coronary revascularization in the PROactive 05 study
Daniel M Riche, Krista M Dale
Cannabis and Cannabinoid Research
|
February 19, 2026
Medical Cannabis for the Treatment of Peripheral Neuropathy due to Diabetes: A Systematic Review
Justin J Sherman, Daniel M Riche
Pharmacotherapy
|
June 26, 2010
Bone loss and fracture risk associated with thiazolidinedione therapy
Daniel M Riche, S Travis King
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
July 25, 2007
Role of statins for the primary prevention of cardiovascular disease in patients with type 2 diabetes mellitus
Daniel M Riche, Katie S McClendon
Pharmacotherapy
|
December 2, 2009
Xanthomas associated with homozygous familial hypercholesterolemia
Daniel M Riche, Honey E East
The Annals of Pharmacotherapy
|
July 28, 2012
Denosumab, a RANK ligand inhibitor, for postmenopausal women with osteoporosis
Emily E Sutton, Daniel M Riche
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
October 23, 2016
Implications of ASHP's Phase II Match process
Daniel M Riche, Kayla S Douglas, Jeanna Sewell
Diabetes Care
|
January 30, 2007
Thiazolidinediones and risk of repeat target vessel revascularization following percutaneous coronary intervention: a meta-analysis
Daniel M Riche, Rodrigo Valderrama, Nickole N Henyan
Journal of Clinical & Translational Endocrinology
|
October 26, 2017
Evidence-based review of statin use in patients with HIV on antiretroviral therapy
Daniel B Chastain, Kayla R Stover, Daniel M Riche
Page
of 5
Search research articles
Search
Showing results (1-10 of 47) with videos related to
Sort By:
Page
of 5
Lancet (London, England)
|
October 15, 2015
EXAMINE: targeting risk and treatment in diabetes
Daniel M Riche, Courtney Davis
Journal of the American College of Cardiology
|
October 24, 2007
A perspective on coronary revascularization in the PROactive 05 study
Daniel M Riche, Krista M Dale
Cannabis and Cannabinoid Research
|
February 19, 2026
Medical Cannabis for the Treatment of Peripheral Neuropathy due to Diabetes: A Systematic Review
Justin J Sherman, Daniel M Riche
Pharmacotherapy
|
June 26, 2010
Bone loss and fracture risk associated with thiazolidinedione therapy
Daniel M Riche, S Travis King
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
July 25, 2007
Role of statins for the primary prevention of cardiovascular disease in patients with type 2 diabetes mellitus
Daniel M Riche, Katie S McClendon
Pharmacotherapy
|
December 2, 2009
Xanthomas associated with homozygous familial hypercholesterolemia
Daniel M Riche, Honey E East
The Annals of Pharmacotherapy
|
July 28, 2012
Denosumab, a RANK ligand inhibitor, for postmenopausal women with osteoporosis
Emily E Sutton, Daniel M Riche
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
October 23, 2016
Implications of ASHP's Phase II Match process
Daniel M Riche, Kayla S Douglas, Jeanna Sewell
Diabetes Care
|
January 30, 2007
Thiazolidinediones and risk of repeat target vessel revascularization following percutaneous coronary intervention: a meta-analysis
Daniel M Riche, Rodrigo Valderrama, Nickole N Henyan
Journal of Clinical & Translational Endocrinology
|
October 26, 2017
Evidence-based review of statin use in patients with HIV on antiretroviral therapy
Daniel B Chastain, Kayla R Stover, Daniel M Riche
Page
of 5